论文部分内容阅读
目的:观察中西医结合治疗晚期非小细胞肺癌的临床疗效。方法:选取晚期非小细胞肺癌患者50例,按随机数字表法分为实验组和对照组各25例,对照组应用NP方案进行化疗治疗,实验组在对照组化疗基础上应用复方苦参注射液治疗,比较两组临床治疗效果。结果:实验组总有效率为72.0%,高于对照组的52.0%(P<0.05);实验组出现恶心呕吐、口腔溃疡、腹泻、白细胞减少、血小板减少的例数均少于对照组(P<0.05)。结论:中西医结合治疗晚期非小细胞肺癌疗效显著,安全性高,值得临床推广应用。
Objective: To observe the clinical efficacy of integrated traditional Chinese and western medicine in the treatment of advanced non-small cell lung cancer. Methods: Fifty patients with advanced non-small cell lung cancer were selected and randomly divided into experimental group and control group (n = 25). The control group received chemotherapy with NP regimen. The experimental group was treated with compound matrine injection Liquid treatment, the clinical efficacy of the two groups were compared. Results: The total effective rate was 72.0% in the experimental group, which was higher than that in the control group (52.0%, P <0.05). The number of nausea and vomiting, oral ulcer, diarrhea, leukopenia and thrombocytopenia in the experimental group were less than those in the control group <0.05). Conclusion: The combination of traditional Chinese and Western medicine in the treatment of advanced non-small cell lung cancer has obvious curative effect and high safety. It is worthy of clinical application.